Patients With MASH Finally Have Options. Let’s Not Let Access Be the Barrier
For years, people living with metabolic dysfunction-associated steatohepatitis (MASH), formerly known as Non-Alcoholic...
Resources
CareMetx Joins Syneos Health to Discuss Modernizing Patient Services and Innovation Strategy
May 21, 2025 by CareMetx
At this year’s Asembia summit, CareMetx Chief Strategy Officer Greg Morris joined a live recording of the Syneos Health...
Drug Channels: IRA Fallout is Changing the Medicare Access Landscape
May 1, 2025 by CareMetx
The Inflation Reduction Act (IRA) promised major wins for patients. In many ways, it’s delivering. But CareMetx's...
Here’s Why You Should Retain Allscripts (MDRX) Stock For Now
Nov 22, 2021 by CareMetx
Allscripts Healthcare Solutions, Inc. MDRX is well-poised for growth in the coming quarters, backed by its strategic...
A Conversation with Mark Hansan, CareMetx
Mar 8, 2020 by CareMetx
CareMetx was founded in 2011 by two longtime industry executives, Bob Dresing and Mark Hansan, who started in the...
Value-based agreements could disrupt how we pay for new therapies
Aug 4, 2019 by CareMetx
On Tuesday, the Senate Finance Committee will hold its second hearing in a series on drug pricing. Led by chairman...
CareMetx Appoints Brian Flaherty as Chief Commercial Officer, Names Shabbir Ahmed Chief Growth Officer
Jun 3, 2025 by CareMetx
Bethesda, MD, June 3, 2025 -- CareMetx, a leading technology-enabled services company dedicated to improving patient...
CareMetx Offers Highest Patient Automation, Reach for Electronic Prescription Benefit Verification
Jan 9, 2025 by CareMetx
Bethesda, MD, January 7, 2025 – CareMetx, a leading technology-enabled hub services platform facilitating patient...
CareMetx Welcomes Scott Genone as Chief Product Officer
Nov 4, 2024 by CareMetx
Genone brings over 30 years of healthcare technology leadership, set to elevate product innovation and patient access....
Case Study: CareMetx Facilitates Seamless Vaccine Access While Outperforming SLA Criteria
May 9, 2024 by CareMetx
This global biopharmaceutical company worked with CareMetx to improve patient access to two of its vaccines. CareMetx's...
CareMetx Leverages AI and Best Practices to Complete 450k+Annual Reverifications Accurately and Ahead of Schedule
May 3, 2024 by CareMetx
CareMetx employed AI and best practices to expedite over 450,000 annual reverifications (AR), ensuring patients receive...
Case Study: CareMetx leveraged specialized patient support services to help navigate the hurdles associated with biosimilar products.
Feb 16, 2024 by CareMetx
CareMetx leveraged specialized patient support services to help navigate the hurdles associated with biosimilar...